Search by Drug Name or NDC

    NDC 52817-0385-10 Glipizide 2.5 mg/1 Details

    Glipizide 2.5 mg/1

    Glipizide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by TruPharma LLC. The primary component is GLIPIZIDE.

    Product Information

    NDC 52817-0385
    Product ID 52817-385_076b74ec-ead5-781c-e063-6394a90ab362
    Associated GPIs
    GCN Sequence Number 017400
    GCN Sequence Number Description glipizide TABLET 2.5 MG ORAL
    HIC3 C4K
    HIC3 Description ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE
    GCN 10842
    HICL Sequence Number 000803
    HICL Sequence Number Description GLIPIZIDE
    Brand/Generic Generic
    Proprietary Name Glipizide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Glipizide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name GLIPIZIDE
    Labeler Name TruPharma LLC
    Pharmaceutical Class Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA214874
    Listing Certified Through 2024-12-31

    Package

    NDC 52817-0385-10 (52817038510)

    NDC Package Code 52817-385-10
    Billing NDC 52817038510
    Package 100 TABLET in 1 BOTTLE (52817-385-10)
    Marketing Start Date 2023-10-03
    NDC Exclude Flag N
    Pricing Information N/A